1.05% -0.345

Indivior Plc (INDV)

개요 뉴스 가격 이력 토론 예측

Relative Volume:

Indivior Plc Stock (INDV) Company Profile

Indivior Plc

Healthcare (1115)

804-379-1090

234 BATH ROAD, SLOUGH, BERKSHIRE

최신 SEC 제출 서류

INDV's Discussions on Twitter

INDV을(를) 다른 주식과 비교

주식	가격	시가총액	매출	순이익	현금흐름	주당 순 이익
INDV Indivior Plc	32.54	4.11B	1.12B	5.00M	-383.00M	0.01
ZTS Zoetis Inc	124.65	55.21B	9.40B	2.65B	2.24B	5.935
TAK Takeda Pharmaceutical Co Adr	16.16	51.59B	29.63B	260.53M	5.51B	0.0788
HLN Haleon Plc Adr	9.83	43.51B	14.26B	1.98B	2.47B	0.4327
TEVA Teva Pharmaceutical Industries Ltd Adr	31.76	37.11B	16.88B	666.71M	251.19M	0.6132
UTHR United Therapeutics Corp	464.93	20.32B	3.08B	1.24B	1.07B	25.61

Indivior Plc Stock (INDV) Upgrades & Downgrades

날짜	액션	분석자	등급 변경
2025-08-06	개시	H.C. Wainwright	Buy
2025-07-22	재개	Jefferies	Buy
2025-01-28	개시	Rodman & Renshaw	Buy
2024-07-23	개시	Piper Sandler	Overweight
2024-04-03	개시	Craig Hallum	Buy
2023-07-13	개시	Northland Capital	Outperform

Indivior Plc 주식(INDV)의 최신 뉴스

Indivior Plc (INDV) 재무 분석

Indivior Plc (INDV)

Indivior Plc Stock (INDV) Company Profile

INDV을(를) 다른 주식과 비교

Indivior Plc Stock (INDV) Upgrades & Downgrades

Indivior Plc 주식(INDV)의 최신 뉴스

Grail and Indivior PLC come out on top in healthcare quant picks ahead of Q4 earnings - MSN

Market Wrap: Will WNEB outperform small cap indexes2025 Sector Review & Trade Opportunity Analysis - baoquankhu1.vn

Indivior (NASDAQ:INDV) Downgraded to "Hold" Rating by Zacks Research - MarketBeat

Indivior PLC: How a Specialist Addiction Franchise Is Quietly Rebuilding a Global Pharma Contender - AD HOC NEWS

Indivior (INDV) Price Target Increased by 13.21% to 43.71 - Nasdaq

Q1 Earnings Forecast for Indivior Issued By HC Wainwright - MarketBeat

Portfolio Update: Is now the right time to enter Indivior PLCJuly 2025 Chart Watch & Accurate Entry/Exit Alerts - baoquankhu1.vn

Indivior PLC (INDV) Stock Analysis: Exploring a 24% Upside Potential in the Healthcare Sector - DirectorsTalk Interviews

Aug Setups: Does Indivior PLC stock trade at a discount to peersMarket Activity Summary & Safe Capital Growth Tips - Bộ Nội Vụ

Risks Report: Will Indivior PLC stock remain a Wall Street favorite2025 Technical Patterns & Free Real-Time Volume Trigger Notifications - Bộ Nội Vụ

Sanofi's Teizeild Gets EU Approval for Treating Type 1 Diabetes - Finviz

HC Wainwright Estimates Indivior's Q2 Earnings (NASDAQ:INDV) - MarketBeat

51,426 Shares in Indivior PLC $INDV Purchased by KLP Kapitalforvaltning AS - MarketBeat

Volume Recap: Is Indivior PLC forming higher highs and higher lows2025 Market Sentiment & Verified Entry Point Signals - baoquankhu1.vn

TEVA Signs Deal With RPRX to Accelerate Development of Vitiligo Drug - Finviz

Take the Zacks Approach to Beat the Markets: Indivior, FIGS & Ulta Beauty in Focus - Yahoo Finance

Indivior stock price target raised to $48 from $35 at H.C. Wainwright - Investing.com Nigeria

INDV: Analyst Raises Price Target to $48.00, Maintains Buy Ratin - GuruFocus

Naloxone Market Is Going to Boom |EMERGENT, Indivior PLC, Akorn, Inc - openPR.com

Indivior PLC (INDV) Announces Full-Year 2026 Financial Guidance - Finviz

Indivior (NasdaqGS:INDV) Valuation Check After Strong Long Term Returns And Recent Price Consolidation - Yahoo Finance

Indivior PLCOrdinary Shares (NQ: INDV - FinancialContent

Indivior forecasts 11% SUBLOCADE growth, 35% EBITDA increase for 2026 By Investing.com - Investing.com Nigeria

Craig-Hallum raises Indivior stock price target to $50 on strong 2026 outlook - Investing.com Nigeria

Aug Closing: Why hedge funds are buying Indivior PLC stockWall Street Watch & Safe Entry Trade Signal Reports - moha.gov.vn

Can Indivior PLC stock double in next 5 years2025 Volume Leaders & Safe Entry Point Alerts - ulpravda.ru

Why Indivior PLC (2IVB) stock is a strong analyst pickWeekly Risk Summary & Safe Entry Point Identification - ulpravda.ru

Why retail investors pile into Indivior PLC stockJuly 2025 Momentum & Fast Moving Market Watchlists - ulpravda.ru

Is Indivior PLC stock a top pick in earnings season2025 Macro Impact & Fast Exit Strategy with Risk Control - ulpravda.ru

What margin trends mean for Indivior PLC stockWeekly Trade Report & Real-Time Chart Pattern Alerts - ulpravda.ru

GLUE Stock Up 45% on Positive Interim Data on Inflammation Drug - Finviz

Published on: 2026-01-08 20:56:58 - ulpravda.ru

How Indivior PLC stock performs during Fed tightening cycles2025 Key Lessons & Stepwise Entry/Exit Trade Alerts - ulpravda.ru

What analyst consensus says on Indivior PLC stock2025 AllTime Highs & Daily Technical Stock Forecast Reports - ulpravda.ru

Indivior Issues FY 2026 Financial Guidance - Nasdaq

Indivior shares rise after FY26 guidance tops consensus expectations By Investing.com - Investing.com Nigeria

Indivior PLC Provides Earnings Guidance for the Full Year 2026 - marketscreener.com

Indivior Expects Up to $1.20 Billion in 2026 Net Revenue - MarketScreener

(INDV) Indivior Expects 2026 Revenue Range $1.13B$1.2B, vs. FactSet Est of $1.19B - MarketScreener

Indivior forecasts 11% SUBLOCADE growth, 35% EBITDA increase for 2026 - Investing.com

Indivior PLC Announces Full-Year 2026 Financial Guidance and Business Highlights - Quiver Quantitative

Indivior : Financial Document - MarketScreener

Indivior PLC Provides 2026 Financial Guidance and Business Update - TradingView — Track All Markets

Indivior Provides Full-Year 2026 Financial Guidance and Business Update - Bluefield Daily Telegraph

Opioid treatment maker Indivior maps 2026 growth and U.S. move - Stock Titan

Indivior price target raised to $40 from $30 at Northland - MSN

Is Indivior (NasdaqGS:INDV) Still Attractive After A 192% One Year Share Price Jump - Yahoo Finance

Indivior (NASDAQ:INDV) Director Purchases $27,427.25 in Stock - MarketBeat

Indivior director Stejbach buys $27,429 in shares By Investing.com - Investing.com South Africa

Insider Buying: Barbara Ryan Acquires Shares of Indivior PLC - GuruFocus

Ryan Barbara, Indivior director, buys $27,429 in shares By Investing.com - Investing.com Australia

Indivior Plc (INDV) 재무 분석

매출

순이익

현금흐름

주당 순 이익

INDV과 유사한 종목